{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:21:31Z","timestamp":1759159291862},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09431-4","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:03:03Z","timestamp":1675425783000},"page":"3682-3692","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model"],"prefix":"10.1007","volume":"33","author":[{"given":"Xue-Song","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai-Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Qiang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"9431_CR1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","volume":"365","author":"WI Wei","year":"2005","unstructured":"Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365:2041\u20132054","journal-title":"Lancet"},{"key":"9431_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"9431_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394:64\u201380","journal-title":"Lancet"},{"key":"9431_CR4","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","volume":"51","author":"M Zhang","year":"2015","unstructured":"Zhang M, Li J, Shen G et al (2015) Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer 51:2587\u20132595","journal-title":"Eur J Cancer"},{"key":"9431_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2019.06.2549","volume":"105","author":"XS Sun","year":"2019","unstructured":"Sun XS, Liu SL, Luo MJ et al (2019) The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012. Int J Radiat Oncol Biol Phys 105:581\u2013590","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9431_CR6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Y Sun","year":"2016","unstructured":"Sun Y, Li W, Chen N et al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17:1509\u20131520","journal-title":"Lancet Oncol"},{"key":"9431_CR7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ et al (2019) Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med 381:1124\u20131135","journal-title":"N Engl J Med"},{"key":"9431_CR8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/00005537-200007000-00018","volume":"110","author":"K Chang","year":"2000","unstructured":"Chang K, Tsang N, Chen C, Su J, Hao S (2000) Endoscopic management of skull base osteoradionecrosis. Laryngoscope 110:1162\u20131165","journal-title":"Laryngoscope"},{"key":"9431_CR9","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1097\/01.mlg.0000230435.71328.b9","volume":"116","author":"X Huang","year":"2006","unstructured":"Huang X, Zheng Y, Zhang X et al (2006) Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma. Laryngoscope 116:1626\u20131631","journal-title":"Laryngoscope"},{"key":"9431_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40880-016-0124-0","volume":"35","author":"YH Yu","year":"2016","unstructured":"Yu YH, Xia WX, Shi JL et al (2016) A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients. Chin J Cancer 35:59","journal-title":"Chin J Cancer"},{"key":"9431_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5732\/cjc.012.10252","volume":"32","author":"MY Chen","year":"2013","unstructured":"Chen MY, Mai HQ, Sun R et al (2013) Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Chin J Cancer 32:533\u2013538","journal-title":"Chin J Cancer"},{"key":"9431_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hed.21036","volume":"31","author":"YJ Hua","year":"2009","unstructured":"Hua YJ, Chen MY, Qian CN et al (2009) Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma. Head Neck 31:807\u2013812","journal-title":"Head Neck"},{"key":"9431_CR13","doi-asserted-by":"crossref","unstructured":"Tang LQ, Li CF, Li J et al (2016) Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst 108(1):djv291","DOI":"10.1093\/jnci\/djv291"},{"key":"9431_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jjco\/hyz165","volume":"50","author":"Z Fei","year":"2020","unstructured":"Fei Z, Qiu X, Li M, Chen C, Li Y, Huang Y (2020) Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis. Jpn J Clin Oncol 50:159\u2013168","journal-title":"Jpn J Clin Oncol"},{"key":"9431_CR15","volume":"10","author":"X Chen","year":"2020","unstructured":"Chen X, Cao X, Jing B et al (2020) Prognostic and treatment guiding significance of MRI-based tumor burden features and nodal necrosis in nasopharyngeal carcinoma. Front Oncol 10:537318","journal-title":"Front Oncol"},{"key":"9431_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/ijbs.24374","volume":"14","author":"J Li","year":"2018","unstructured":"Li J, Chen S, Peng S et al (2018) Prognostic nomogram for patients with nasopharyngeal carcinoma incorporating hematological biomarkers and clinical characteristics. Int J Biol Sci 14:549\u2013556","journal-title":"Int J Biol Sci"},{"key":"9431_CR17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/djaa149","volume":"113","author":"M Qiang","year":"2021","unstructured":"Qiang M, Li C, Sun Y et al (2021) A prognostic predictive system based on deep learning for locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 113:606\u2013615","journal-title":"J Natl Cancer Inst"},{"key":"9431_CR18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2014.10.005","volume":"91","author":"LQ Tang","year":"2015","unstructured":"Tang LQ, Li CF, Chen QY et al (2015) High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study. Int J Radiat Oncol Biol Phys 91:325\u2013336","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9431_CR19","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/STROKEAHA.119.025054","volume":"50","author":"J Feghali","year":"2019","unstructured":"Feghali J, Yang W, Xu R et al (2019) R(2)eD AVM score. Stroke 50:1703\u20131710","journal-title":"Stroke"},{"key":"9431_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.radonc.2013.08.003","volume":"110","author":"C Chen","year":"2014","unstructured":"Chen C, Shen LJ, Li BF, Gao J, Xia YF (2014) Smoking is a poor prognostic factor for male nasopharyngeal carcinoma treated with radiotherapy. Radiother Oncol 110:409\u2013415","journal-title":"Radiother Oncol"},{"key":"9431_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2020.00255","volume":"10","author":"XS Sun","year":"2020","unstructured":"Sun XS, Xiao BB, Lu ZJ et al (2020) Stratification of candidates for induction chemotherapy in stage III-IV nasopharyngeal carcinoma: a large cohort study based on a comprehensive prognostic model. Front Oncol 10:255","journal-title":"Front Oncol"},{"key":"9431_CR22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/bjc.2013.343","volume":"109","author":"PY Ouyang","year":"2013","unstructured":"Ouyang PY, Su Z, Mao YP, Liang XX, Liu Q, Xie FY (2013) Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma. Br J Cancer 109:788\u2013794","journal-title":"Br J Cancer"},{"key":"9431_CR23","volume":"10","author":"SS Guo","year":"2015","unstructured":"Guo SS, Tang LQ, Chen QY et al (2015) Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity-modulated radiotherapy technology?\u00a0PLoS One\u00a010:e0136033","journal-title":"PLoS One"},{"key":"9431_CR24","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","volume":"94","author":"AT Chan","year":"2002","unstructured":"Chan AT, Lo YM, Zee B et al (2002) Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94:1614\u20131619","journal-title":"J Natl Cancer Inst"},{"key":"9431_CR25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310\u20131317","journal-title":"J Clin Oncol"},{"key":"9431_CR26","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1200\/JCO.2004.00.7542","volume":"23","author":"AW Lee","year":"2005","unstructured":"Lee AW, Lau WH, Tung SY et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966\u20136975","journal-title":"J Clin Oncol"},{"key":"9431_CR27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/cncr.20099","volume":"100","author":"JY Shao","year":"2004","unstructured":"Shao JY, Li YH, Gao HY et al (2004) Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer 100:1162\u20131170","journal-title":"Cancer"},{"key":"9431_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.02.012","volume":"67","author":"Q Yang","year":"2017","unstructured":"Yang Q, Zou X, You R et al (2017) Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis. Oral Oncol 67:83\u201388","journal-title":"Oral Oncol"},{"key":"9431_CR29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radonc.2008.02.003","volume":"87","author":"AW Lee","year":"2008","unstructured":"Lee AW, Lau KY, Hung WM et al (2008) Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma. Radiother Oncol 87:204\u2013210","journal-title":"Radiother Oncol"},{"key":"9431_CR30","doi-asserted-by":"crossref","unstructured":"Lin S, Lu JJ, Han L, Chen Q, Pan J (2010) Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer 10:39","DOI":"10.1186\/1471-2407-10-39"},{"key":"9431_CR31","first-page":"1132","volume":"28","author":"Z Yu","year":"2009","unstructured":"Yu Z, Luo W, Zhou QC, Zhang QH, Kang DH, Liu MZ (2009) Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma. Ai Zheng 28:1132\u20131137","journal-title":"Ai Zheng"},{"key":"9431_CR32","volume":"10","author":"SL Liu","year":"2020","unstructured":"Liu SL, Sun XS, Lu ZJ et al (2020) Nomogram predicting the benefits of adding concurrent chemotherapy to intensity-modulated radiotherapy after induction chemotherapy in stages II-IVb nasopharyngeal carcinoma. Front Oncol 10:539321","journal-title":"Front Oncol"},{"key":"9431_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","volume":"19","author":"XR Tang","year":"2018","unstructured":"Tang XR, Li YQ, Liang SB et al (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19:382\u2013393","journal-title":"Lancet Oncol"},{"key":"9431_CR34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","volume":"16","author":"A Clocchiatti","year":"2016","unstructured":"Clocchiatti A, Cora E, Zhang Y, Dotto GP (2016) Sexual dimorphism in cancer. Nat Rev Cancer 16:330\u2013339","journal-title":"Nat Rev Cancer"},{"key":"9431_CR35","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.7150\/jca.35311","volume":"10","author":"YF Wen","year":"2019","unstructured":"Wen YF, Sun XS, Yuan L et al (2019) The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis. J Cancer 10:5614\u20135621","journal-title":"J Cancer"},{"key":"9431_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/0284186X.2012.742964","volume":"52","author":"CR B\u00f8je","year":"2013","unstructured":"B\u00f8je CR, Dalton SO, Gr\u00f8nborg TK et al (2013) The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database. Acta Oncol 52:285\u2013293","journal-title":"Acta Oncol"},{"key":"9431_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.radonc.2018.09.004","volume":"129","author":"XD Huang","year":"2018","unstructured":"Huang XD, Zhou GQ, Lv JW et al (2018) Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis. Radiother Oncol 129:389\u2013395","journal-title":"Radiother Oncol"},{"key":"9431_CR38","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"JC Lin","year":"2004","unstructured":"Lin JC, Wang WY, Chen KY et al (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350:2461\u20132470","journal-title":"N Engl J Med"},{"key":"9431_CR39","volume":"99","author":"J Wu","year":"2020","unstructured":"Wu J, Zhou Q, Pan Z et al (2020) Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: a population-based study.\u00a0Medicine (Baltimore)\u00a099:e18974","journal-title":"Medicine (Baltimore)"},{"key":"9431_CR40","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/cam4.2841","volume":"9","author":"XS Sun","year":"2020","unstructured":"Sun XS, Xiao BB, Lin C et al (2020) Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: analysis based on a large cohort. Cancer Med 9:1661\u20131670","journal-title":"Cancer Med"},{"key":"9431_CR41","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.2147\/CMAR.S197841","volume":"11","author":"XY Li","year":"2019","unstructured":"Li XY, Sun XS, Liu SL et al (2019) The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study. Cancer Manag Res 11:6253\u20136263","journal-title":"Cancer Manag Res"},{"key":"9431_CR42","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1200\/JCO.2017.77.1790","volume":"36","author":"JJ Hu","year":"2018","unstructured":"Hu JJ, Urbanic JJ, Case LD et al (2018) Association between inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in a multiracial\/ethnic breast cancer population. J Clin Oncol 36:2473\u20132482","journal-title":"J Clin Oncol"},{"key":"9431_CR43","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hed.21848","volume":"34","author":"FF Mohammed","year":"2012","unstructured":"Mohammed FF, Poon I, Zhang L et al (2012) Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck 34:985\u2013993","journal-title":"Head Neck"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09431-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:10:18Z","timestamp":1682079018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["9431"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09431-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Hai-Qiang Mai.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Xue-Song Sun and Sai-Lan Liu kindly provided statistical advice for this manuscript. No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}